Synthesis of C5-substituted imidazolines

被引:9
作者
Defacqz, N
Van, TT
Cordi, A
Marchand-Brynaert, J
机构
[1] Univ Catholique Louvain, Unite Chim Organ & Med, B-1348 Louvain, Belgium
[2] Inst Rech Servier, F-92150 Suresnes, France
关键词
imidazoline; Mitsunobu reaction;
D O I
10.1016/j.tetlet.2003.10.044
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
5-(Hydroxymethyl)-3-(t-butyloxycarbonyl)imidazoline 2 was prepared in four steps from 2,3-diaminopropionic acid in 72% overall yield. Mitsunobu reaction with a series of phenol derivatives gave the corresponding 5-(aryloxymethyl)-3-(t-butyloxycarbonyl)imidazolines 8a-1. Phthalimide and N-benzyl trifluoroacetamide also reacted. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:9111 / 9114
页数:4
相关论文
共 32 条
[1]   Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands [J].
Anastassiadou, M ;
Danoun, S ;
Crane, L ;
Baziard-Mouysset, G ;
Payard, M ;
Caignard, DH ;
Rettori, MC ;
Renard, P .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) :585-592
[2]   A novel general route for the preparation of enantiopure imidazolines [J].
Boland, NA ;
Casey, M ;
Hynes, SJ ;
Matthews, JW ;
Smyth, MP .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (11) :3919-3922
[3]   Drugs acting on imidazoline receptors - A review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection [J].
Bousquet, P ;
Feldman, J .
DRUGS, 1999, 58 (05) :799-812
[4]   Imidazoline receptors in cardiovascular and metabolic diseases [J].
Bousquet, P ;
Dontenwill, M ;
Greney, H ;
Feldman, J .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 :S21-S25
[5]   STIMULATION OF INSULIN-SECRETION BY THE IMIDAZOLINE ALPHA-2-ADRENOCEPTOR ANTAGONIST EFAROXAN IS MEDIATED BY A NOVEL, STEREOSELECTIVE, BINDING-SITE [J].
CHAN, SLF ;
BROWN, CA ;
MORGAN, NG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (03) :375-378
[6]   (S)-spiro[(1,3-diazacyclopent-1-ene)-5,2'-(7'-methyl-1',2',3',4'-tetrahydronaphthalene)]: Resolution, stereospecific synthesis, and preliminary pharmacological characterization as a partial alpha-adrenergic agonist [J].
Cordi, AA ;
Lacoste, JM ;
LeBorgne, F ;
Herve, Y ;
VaysseLudot, L ;
Descombes, JJ ;
Courchay, C ;
Laubie, M ;
Verbeuren, TJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (18) :2931-2935
[7]   Potential antidepressants displayed combined α2-adrenoceptor antagonist and monoamine uptake inhibitor properties [J].
Cordi, AA ;
Berque-Bestel, I ;
Persigand, T ;
Lacoste, JM ;
Newman-Tancredi, A ;
Audinot, V ;
Millan, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) :787-805
[8]   DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NEW SERIES OF ALPHA-ADRENERGIC AGONISTS - SPIRO[(1,3-DIAZACYCLOPENT-1-ENE)-5,2'-(1',2',3',4'-TETRAHYDRONAPHTHALENE)] [J].
CORDI, AA ;
LACOSTE, JM ;
DESCOMBES, JJ ;
COURCHAY, C ;
VANHOUTTE, PM ;
LAUBIE, M ;
VERBEUREN, TJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (20) :4056-4069
[9]   I2-imidazoline binding site affinity of a structurally different type of ligands [J].
Dardonville, C ;
Rozas, I ;
Callado, LF ;
Meana, JJ .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (05) :1525-1533
[10]   Imidazoline receptor proteins in brains of patients with Alzheimer's disease [J].
García-Sevilla, JA ;
Escribá, PV ;
Walzer, C ;
Bouras, C ;
Guimón, J .
NEUROSCIENCE LETTERS, 1998, 247 (2-3) :95-98